⌘K

Home/Filings/4/0001493152-23-002833

4//SEC Filing

Gudin Jeffrey 4

Accession 0001493152-23-002833

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 8:30 PM ET

Size

5.3 KB

Accession

0001493152-23-002833

Insider Transaction Report

Form 4

Period: 2023-01-25

Virpax Pharmaceuticals, Inc.VRPX

DirectorChief Medical Officer

Transactions

Award
Stock Option (right to buy)
2023-01-25+50,000→ 50,000 total
Exercise: $0.79Exp: 2033-01-25→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments commencing on January 25, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818449

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 8:30 PM ET
Size: 5.3 KB

View on SEC.gov